The weekly litigation news digest is live. Subscribe now

Conjugate Of Galnac And Saponin, Therapeutic Composition Comprising Said Conjugate And A Galnac-Oligonucleotide Conjugate - EP4171641

The patent EP4171641 was granted to Sapreme on Oct 30, 2024. The application was originally filed on Jun 18, 2021 under application number EP21734241A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4171641

SAPREME
Application Number
EP21734241A
Filing Date
Jun 18, 2021
Status
Granted And Under Opposition
Sep 27, 2024
Publication Date
Oct 30, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJul 29, 2025ELKINGTON AND FIFEADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2011054811
INTERNATIONAL-SEARCH-REPORTWO2020126604
OPPOSITIONWO2011054811

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents